Sheryl Stevenson is a journalist who specializes in ophthalmology and optometry topics. She writes for Ophthalmology Times and Optometry Times, covering industry updates, advancements in eye care, and important topics related to eye health. Sheryl's articles provide valuable insights for professionals in the field and aim to raise awareness about eye diseases and advancements in treatment.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Sheryl Stevenson's coverage heavily focuses on ophthalmology, eye care conferences, and innovation in the field. Her articles often include expert commentary and cite data, indicating a preference for well-informed sources who can provide authoritative insights into developments within ophthalmology practices and related technologies.
Given the emphasis on scientific themes and healthcare & pharmaceutical topics, Sheryl may be receptive to pitches that offer in-depth analysis of emerging trends or innovations within the ophthalmology field. She appears to have an international view of these topics without a specific geographic focus mentioned.
If you are reaching out to Sheryl with a pitch, ensure that your expertise aligns with the latest advancements in Ophthalmology or related technologies.
This information evolves through artificial intelligence and human feedback. Improve this profile .
MJH Life Sciences ® - Ophthalmology news, articles, and events. All rights reserved.
By: Sheryl Stevenson
Ferhina S. Ali, MD, discussed the real-world efficacy and durability of next-generation anti-VEGF agents like faricimab and aflibercept 8 mg, emphasizing how large-scale data offers insights into their performance and safety beyond clinical trials.
By: Sheryl Stevenson
Program director and co-founder Bonnie An Henderson, MD, sits down with Ophthalmology Times to talk about how the annual conference is a unique blend of cutting-edge science, professional growth, and community. The 2025 conference will take place February 14 to 17 at the Caribe Hilton San Juan, in Puerto Rico.
MJH Life Sciences ® - Ophthalmology news, articles, and events. All rights reserved.
By: Martin David Harp, Sheryl Stevenson, David Hutton, Sydney M Crago
In this series, experts in the field advise current residents and offer insight into how they can make the most of their time and experience moving forward with their careers.
By: Martin David Harp, Sydney M Crago, David Hutton, Sheryl Stevenson
In this series, experts in the field advise current residents and offer insight into how they can make the most of their time and experience moving forward with their careers.
By: Sydney M Crago, David Hutton, Sheryl Stevenson, Martin David Harp
This series features experts in ophthalmology sharing their thoughts on the one unsolved challenge they wish there was a solution for.
By: Sydney M Crago, Sheryl Stevenson, Martin David Harp, David Hutton
This series features experts in ophthalmology sharing their thoughts on the one unsolved challenge they wish there was a solution for.
By: Sheryl Stevenson, David Hutton, Sydney M Crago, Martin David Harp
This series features experts in ophthalmology sharing their thoughts on the one unsolved challenge they wish there was a solution for.
By: Sheryl Stevenson
Lana Rifkin, MD, a uveitis specialist at Ophthalmic Consultants of Boston, shared insights into her work and her role as committee chair of the uveitis section for the upcoming EnVision Summit, which will be held from February 14 to 17, 2025, at the Caribe Hilton San Juan in Puerto Rico.
(833) 317-6278 
